<DOC>
	<DOCNO>NCT00756288</DOCNO>
	<brief_summary>Evaluating safety efficacy use topical retinoid photodynamic therapy treatment actinic keratoses .</brief_summary>
	<brief_title>Photo-therapy With Topical Retinoid Versus Photo-therapy Alone Actinic Keratoses</brief_title>
	<detailed_description>Evaluating safety efficacy use topical retinoid photodynamic therapy v photodynamic therapy alone treatment actinic keratoses .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Photosensitizing Agents</mesh_term>
	<criteria>Inclusion Criteria Adults age 1880 year old Subjects AK lesion receive PDT Subjects AK lesion two area face scalp surface area 10cm2 great least 3 clinically diagnosed nonhypertrophic AK lesion Subjects good health Subjects willingness ability understand provide inform consent Exclusion Criteria Subjects pregnant lactating Subjects history cutaneous photosensitivity porphyria , hypersensitivity porphyrin , photodermatosis Subjects use photosensitize drug within 1 week study start Subjects use topical medication corticosteroid , alphahydroxyacids retinoids 2 week study entry Subjects receive previous treatment target AKs within 4 week Subjects unable understand protocol give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Actinic Keratoses</keyword>
	<keyword>Blue light therapy</keyword>
	<keyword>photosensitizer</keyword>
	<keyword>Retinoid</keyword>
</DOC>